Basic Information
| LncRNA/CircRNA Name | LOC730100 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR, Luciferase reporter assay |
| Sample | glioma tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | Furthermore, LOC730100 upregulation is linked to a poor prognosis in glioma patients.In conclusion, our findings revealed that LOC730100 promoted glioma progression through regulating miR-760/FOXA1 axis. |
| Pubmed ID | 30914197 |
| Year | 2019 |
| Title | Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA. |
External Links
| Links for LOC730100 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |